Ubiquitin-proteasome pathway in the pathogenesis of liver disease
Ubiquitin-proteasome pathway in the pathogenesis of liver disease
复制标题
DOI:
10.1007/3-540-27194-5_32
复制
发表时间:
2005-01-01
期刊:
影响因子:
--
通讯作者:
Bardag-Gorce, F
中科院分区:
文献类型:
--
作者:
French, SW;Bardag-Gorce, F
The discovery of the ubiquitin-proteasome pathway as a regulated system of protein digestion within all cells [32] has led to an appreciation of the importance of protein turnover control. This control is a mechanism for regulation of cellular processes and quality control of intracellular proteins. Many liver cell functions are regulated by this mechanism of protein degradation. These include cell cycle check points and activation of transcription factors such as nuclear factor-κB (NF-κB)(Chapter 29), and hypoxia inducible factor-1α (HIF-1α)(Chapter 26)[28, 67, 71]. The loss of proteasomes or the inhibition of the ubiquitin-proteasome pathway can lead to hepatocellular injury including proliferation and apoptosis [74, 107], and hepatic inclusions of aggregated cytokeratins [24]. Liver cell gene expressions, dependent on transcription factor activation by the proteasome, could impede the inflammatory response of the liver and the response to hypoxic injury. The importance of the ubiquitin-proteasome pathway to the homeostatic mechanisms involved in liver injury is the focus of this review.